In addition to finding ways to ferment grape juice without producing as much alcohol, one scientist is exploring novel yeasts and methods to overproduce aromas to compensate for their eventual loss when reducing alcohol through grape juice dilution.
A new study has found that an investigational mRNA influenza vaccine helps the immune system recognize a wider range of influenza viruses than today’s standard flu shot, offering stronger and potentially longer-lasting protection. The vaccine, developed by Moderna, is currently under review by the U.S. Food and Drug Administration.
Researchers have discovered 45 new toxins produced by Salmonella bacteria, some of which are associated with foodborne infections. The study shows that these substances primarily act in the competition among microorganisms for space and resources.
A new study suggests enterobactin, a molecule produced by gut bacteria, could offer a new pathway for treating inflammatory bowel disease.
New findings from the ACTIV-6 randomized clinical trial provide important confirmation of prior clinical trial results that metformin, a widely available and inexpensive medication with an established safety record, reduced the risk of clinician-diagnosed long COVID when started during acute COVID-19 infection.
A new study reveals how the exercise-induced myokine musclin reprograms macrophage metabolism to clear dead cells and treat periprosthetic joint infections.
A new study has found that an investigational mRNA influenza vaccine helps the immune system recognize a wider range of influenza viruses than today’s standard flu shot, offering stronger and potentially longer-lasting protection. The vaccine, developed by Moderna, is currently under review by the U.S. Food and Drug Administration.
Researchers have discovered 45 new toxins produced by Salmonella bacteria, some of which are associated with foodborne infections. The study shows that these substances primarily act in the competition among microorganisms for space and resources.
A new study suggests enterobactin, a molecule produced by gut bacteria, could offer a new pathway for treating inflammatory bowel disease.
At ASM Microbe 2026, Bruker Corporation’s Microbiology & Infection Diagnostics (BMID) division demonstrated its expanding portfolio and innovations across microbial identification, sepsis diagnostics, molecular testing, and NGS workflows, advancing clinical research, and faster, actionable infectious disease diagnostics.
Andelyn Biosciences has announced the launch of its LVV Curator® Platform, a standardized lentiviral vector (LVV) manufacturing solution built on the same proven modular approach that supports clinical and commercial adeno-associated virus (AAV) programs.
Modular Clean Air (MCA) is now wholly owned by Total Clean Air (TCA), marking the next phase in its development following its successful launch as a joint venture in 2025.
In a landmark achievement in biological imaging, researchers have announced the successful demonstration of the laser phase plate, a novel device that dramatically improves the contrast of images produced by cryo-electron microscopes, opening up an entirely new view of human biology.
Encapsulating Beauveria bassiana in a biopolymer made of cellulose and aluminum increased the viability of the fungus from 69% to 85% after five months of storage, providing a more sustainable alternative that releases the bioinsecticide.
New degradable sensors being developed by soil scientists track biological activity in soil by having a degradable substrate that is nibbled on by microbes.
In addition to finding ways to ferment grape juice without producing as much alcohol, one scientist is exploring novel yeasts and methods to overproduce aromas to compensate for their eventual loss when reducing alcohol through grape juice dilution.
With an estimated one million Americans afflicted with post-treatment Lyme disease syndrome, newly funded research seeks to determine whether the condition is triggered by a persistent autoimmune response, and if a test can be devised to pinpoint who is more likely to develop it.
Elsevier has launched an Ebola Information Center to provide healthcare professionals, researchers, policy makers and the public with free access to critical clinical and research information to support the global response to this outbreak.